Cardiac infections in the immunosuppressed patient

Infectious Disease Clinics of North America

Volumn 15, Issue 2, 2001, Pages 613-638

  Brusch, John L ^b  

^a CAMBRIDGE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ASPERGILLUS; BARTONELLA; CANDIDA; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COXIELLA BURNETII; ENDOCARDITIS; ENTEROCOCCUS; EPIDEMIOLOGY; EPSTEIN BARR VIRUS; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNITY; LISTERIA MONOCYTOGENES; MUCORMYCOSIS; MYCOBACTERIUM; NOCARDIA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034953021     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70162-8     Document Type: Article

References (181)

1. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia
2. Increased risk of pneumococcal infections in cardiac transplant recipients
3. Diagnosis of nosocomial pneumonia in acute diffuse lung injury
4. False-positive antitoxoplasma fluorescent antibody tests in patients with antinuclear antibodies
5. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants
6. Bacteremia due to viridans streptococci in neutropenic patients: A review
7. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients
8. Rapid classification of positive blood cultures prospective validation of a multivariance algorithm
9. Endocarditis and intravascular infections
10. Multiple organ failure syndrome in the 1990's: Systemic inflammatory response and organ dysfunction
11. Human cytomegalovirus encodes a glycoprotein homologous to MHC Class I Antigens
12. Toxoplasmosis after bone marrow transplantation
13. Nocardial infection in patients with neoplastic disease
14. Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease
15. Aetiology of chronic constrictive pericarditis
16. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV) infected individuals: A serial echocardiographic study
17. Histoplasma capsulatum endocarditis
18. Diagnosis of catheter-related bacteremia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures
19. Heart transplantation for Chagas' heart disease
20. Long term follow up after heart transplantation in Chagas' disease
21. Aspergillosis
22. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic bone marrow transplantation
23. Cytomegalovirus infection after BMT
24. Reduced rates of catheter associated infection by use of a new silver-impregnated central venous catheter
25. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: The pathogenetic role of the antileukemic regimen
26. Infective endocarditis in critical care
27. Left-sided valvular active infective endocarditis: A study of 45 necropsy patients
28. Cytomegalovirus pericarditis: A case series and review of the literature
29. Fungal purulent constrictive pericarditis in a heart transplant patient
30. Properdin levels in splenectomized persons
31. Chagas' disease diagnosis: Evaluation of several tests in blood bank screening
32. Fatal endocarditis due to Listeria monocytogenes
33. T-cell immunity against cytomegalovirus modifies self-major histocompatibility complex antigens in kidney transplant recipients
34. Cardiac involvement in HIV disease
35. Infective endocarditis caused by gram-negative bacteria: A review of the literature, 1945-1977
36. Primary pulmonary hypertension associated with human immunodeficiency viral infection
37. Pericarditis and electrocardiographic changes in Reiter's syndrome
38. A review of endocarditis in acquired immunodeficiency syndrome and human immunodeficiency virus infection
39. Tuberculous pericarditis as the first manifestation of acquired immunodeficiency syndrome
40. Toxoplasma serology, parasitemia and antigenemia in patients at risk for toxoplasmic encephalitis
41. A comparison of two antimicrobial-impregnated central venous catheters
42. Bacterial pericarditis after heart transplantation: Successful management of two cases with catheter drainage and antibiotics
43. Infections in the immunocompromised host: General principles
44. Immunodiagnosis of invasive fungal infections
45. Toxoplasma antibody titers in renal transplant recipients
46. Toxoplasma infection after human allogenic bone marrow transplantation: Clinical and serological study of 80 patients
47. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukemia - Ciprofloxacin versus cotrimoxazole plus colistin
48. Solid organ transplantation
49. Clinical manifestations and management of candidasis in the compromised patient
50. Aspergillus fungemia. Two cases and review
51. Nosocomial colonization, septicemia, and Hickman/Broviac catheter related infections in bone marrow transplant recipients - A 5-year prospective study
52. Detection of nosocomial lung infection in ventilated patients: Use of a protected specimen brush and quantitative culture techniques in 147 patients
53. Heterotropic prosthetic ventricles as a bridge to cardiac transplantation: A multicenter study in 29 patients
54. Hospital-acquired infectious endocarditis not associated with cardiac surgery: An emerging problem
55. Severe combined immunodeficiencies
56. Fungal infections in the organ transplant recipient: Challenges and opportunities
57. Toxoplasmosis: Mechanisms of infection, laboratory diagnosis and management
58. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: A means for graft rejection and immunosuppression
59. Pericardial disease in AIDS: Frequency of tamponade and therapeutic and diagnostic use of pericardiocentesis
60. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia
61. The epidemiology of listeriosis in the United States-1986
62. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low speed centrifugation and monoclonal antibody to an early antigen
63. Candida krusei fungemia
64. Cytomegalovirus myocarditis as a cause of cardiac dysfunction in a heart transplant recipient
65. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
66. Infection of the heart by the human immunodeficiency virus
67. Three-year experience with human cytomegalovirus infections in heart transplant recepients
68. Fungal infections in solid organ transplant recipients
69. Chagas' heart disease in the United States
70. Toxoplasmosis in cardiac transplantation
71. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation
72. The Epstein-Barr virus in the pathogenesis of post-transplant lymphoproliferative disorders
73. Rheumatoid arthritis: The clinical spectrum
74. Human immunodeficiency virus infection cardiac lesions
75. Surgical management of infective endocarditis after heart-lung transplantation
76. Detection of Aspergillus antigens associated with invasive infection
77. Coxiella burnetii infection in immunocompromised patients
78. Pericardial effusion in AIDS: Incidence and survival
79. Fatal infection in systemic lupus erythematosus: The role of opportunistic organisms
80. The effect of HIV infection on the heart
81. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infections with human immunodeficiency virus
82. Herpes group virus infections in the compromised host
83. Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome
84. Chagas' heart disease
85. Ciproflaxacin in sweat and antibiotic resistance. The Copenhagen Study Group on antibiotics in sweat
86. Pericardial effusion and pericardiocentesis in HIV infection
87. Toxoplasmosis in the non-AIDS immunocompromised host
88. Myocardial dysfunction in patients infected with HIV: Prevalence and risk factors
89. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
90. Reduced intravascular catheter-related infection by routine use of antibiotic bonded catheters in surgical intensive care unit
91. Myocarditis and cardiomyopathy
92. Pathology of the heart in acquired immunodeficiency syndrome (AIDS)
93. Adenosine deaminase and carcinoembryonic antigen and pericardial effusion diagnosis, especially in suspected tuberculosis pericarditis
94. Reoccurrence of Chagas' disease during therapy of acute lymphocytic leukemia
95. Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia
96. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
97. Toxoplasmosis in the setting of AIDS
98. Differences in outcomes for patients with bacteremia caused by vancomycin resistant Enterococcus faecium
99. Cytomegalovirus infection and coronary atherosclerosis after cardiac transplantation
100. Overwhelming myocarditis due to Cryptococcus neoformans in an AIDS patient
101. Fatal cerebral toxoplasmosis in a bone marrow transplant recipient with leukemia
102. Endomycoardial biopsy in the diagnosis of toxoplasmic myocarditis
103. Toxoplasma pericarditis mimicking systemic lupus erythematosus
104. Myocardial involvement in acquired immuno-deficiency syndrome: Incidence in a large autopsy study
105. Pericardial diseases with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods on treatment
106. A semiquantitative culture method for identification of catheter-related infections in the burn patient
107. Infections caused by intravascular devices used for infusion, pathogenesis, prevention and management
108. Infections due to infusion therapy
109. Risk factors for central venous catheter related infection in an ICU: A prospective study of 345 catheter program
110. Catheter-related right-sided endocarditis in bone marrow transplant recipients
111. Cardiac transplantation and aspergillosis
112. Host defenses and susceptibility to infection in patients with diabetes mellitus
113. Transmission of toxoplasmosis by renal transplant
114. The Chicago AIDS autopsy study: Opportunistic infections, neoplasms and findings from selected organ systems with a comparison to national data
115. Cytomegalovirus and myocarditis in a transplanted heart: A case report of in situ hybridization
116. Aspergillus pericarditis: Report of a successfully treated case with tamponade and literature review
117. The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression
118. Myocarditis and pericarditis
119. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes
120. Acute vascular rejection of the coronary arteries in human heart transplantation: Pathology and correlations with immunosuppression and cytomegalovirus infection
121. Infections in patients with Hodgkin's disease: A clinical study of 300 consecutive adult patients
122. Distribution of pathogenic yeast and humoral antibodies to Candida among hospital inpatients
123. Global epidemiology of infectious diseases
124. Clinical evaluation of an EIA for the sensitive and specific detection of serum antibody to Trypanosoma cruzi (Chagas' disease)
125. Primary cutaneous aspergillosis in neonates: Case report and review
126. Evaluation and management of patients with collagen vascular disease
127. Myocarditis - Continuing clinical and pathologic confusion
128. Management of fever in patients with cancer and treatment-induced neutropenia
129. Phenotypes, proliferative responses and suppressor function of lung lymphocytes during Toxoplasma gondii pneumonia in mice
130. Amphoteracin B-resistant yeast infection in severely immunocompromised patients
131. Quantitative oropharyngeaI Epstein-Barr virus shedding in renal and cardiac transplant recipients: Relationship to immuno-suppressive therapy, serological responses and the risk of posttransplant lympho-proliferative disorder
132. Hickman catheter infections in patients with malignancies
133. Infectious complications of indwelling vascular catheters
134. Fungal infections in iatrogenically compromised hosts
135. Disseminated toxoplasmosis with brain involvement in a renal allograft recipient
136. Incidence of Coxsackie virus infection in patients with dilated cardiomyopathy
137. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: Detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right-ventricular endomyocardial biopsy tissue
138. Fatal outcome after combined therapy for myeloblastic leukemia and toxoplasmosis
139. Clinical features of systemic lupus erythematosus
140. Impact of cytomegalovirus on organ transplant recipients
141. Infection in the organ transplant recipient
142. Tuberculous pericarditis: Ten year experience with a prospective protocol for diagnosis and treatment
143. Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: Diagnosis by peripheral blood culture
144. Weight loss and the heart. Effects of anorexia nervosa and starvation
145. Granulocyte-macrophage colony-stimulating factor (GM-CSF) - What role in bone marrow transplantation
146. Risk factors for obliterative bronchiolitis in heart lung transplant recipients
147. Cardiac tamponade complicating cytomegalovirus pericarditis in a patient with AIDS
148. Patterns of candida endocarditis following cardiac surgery: Importance of early diagnosis and therapy (an analysis of 91 cases)
149. Myocardial risk factors other than human immunodeficiency virus infection may contribute to histologic cardiomyopathic changes in acquired immune deficiency syndrome
150. Massive cytomegalovirus pneumonia and myocarditis in a renal transplant recipient: Successful treatment with DHPG
151. Pericardial changes and left ventricular function in ankylosing spondylitis
152. Transmission of toxoplasmosis by leukocyte transfusion
153. Coronary microvascular narrowing in acute murine coxsackie B3 myocarditis
154. Introduction
155. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus
156. Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency virus
157. Listerial myocarditis in cardiac transplantation
158. Tuberculosis pericarditis in transkei
159. Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice
160. The effect of anti-IFN-γ antibody on the protective effect of LYT-2+ immune T-cells against toxoplasmosis in mice
161. Hospital-acquired infective endocarditis
162. Fatal dissemination with Aspergillus terreus in immunocompromised hosts
163. Cerebral toxoplasmosis after renal transplantation. Case report
164. Acute Epstein-Barr virus myocarditis simulating myocardial infarction with cardiogenic shock
165. Myocardial infarct in disseminated mucormycosis: Case report with special emphasis on the pathogenic mechanisms
166. Defects in host defense mechanisms
167. Gonococcal arthritis with pericarditis
168. Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute
169. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients
170. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - A preliminary report
171. Gram-negative infections
172. On the relation between cytomegalovirus infection and rejection after heart transplantation
173. Clinical manifestations of native valve endocarditis
174. Microbiology of infective endocarditis and clinical correlates: Gram-negative and other organisms
175. Clinical utility of echocardiography in suspected infective endocarditis
176. Fatal pericarditis due to Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome
177. The cardiomyopathies and myocarditides
178. Aspergillosis: The spectrum of disease in 98 patients
179. Epstein-Barr virus lymphoproliferation after bone marrow transplantation